Patients that fully recovered from depression
Clinicians using Flow
Eir patients within NHS
Flow offers a much-needed treatment option—at-home tDCS—that can be used alone or alongside existing care to fill a key gap in depression treatment.
Flow is based on Transcranial direct current stimulation as a non-invasive, painless and safe brain stimulation technology.
At-home treatment with built-in onboarding.
Effortlessly review patient’s adherence and progress.
Remarkable results already after 3 weeks.
Standalone or augmented to current treatment plans.
Clinically proven to treat and prevent depression without the side-effects. Used by the NHS. Approved by EMA.
Meet our products
Flow and Flow Connect
At Flow Neuroscience, we are committed to broadening access to clinically effective mental health treatments, empowering clinicians to offer innovative care options for their patients:
Eir and Flow Connect.
Flow
Advanced tDCS neurostimulation device designed for depression treatment with precise, safe electrical stimulation monitored by a comprehensive mobile application that guides treatment sessions.
Flow Connect
Professional monitoring platform for healthcare providers to track patient progress and adjust treatment protocols with Real-time monitoring, Patient dashboard and Clinical insights.
Proven reduction in
symptoms by week 6–10.
Patients track their progress using the MADRS-s within the Flow app.
Average symptom reduction (points by week 10)
Adherence in early treatment weeks
Engagement with mobile guidance
